Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Daiichi Sankyo
Express Scripts
Johnson and Johnson
Covington
Harvard Business School
QuintilesIMS
Fuji
Colorcon

Generated: January 16, 2018

DrugPatentWatch Database Preview

Alpharma Us Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ALPHARMA US PHARMS, and what generic and branded alternatives to ALPHARMA US PHARMS drugs are available?

ALPHARMA US PHARMS has sixty-one approved drugs.



Summary for Alpharma Us Pharms
US Patents:0
Tradenames:43
Ingredients:40
NDAs:61

Drugs and US Patents for Alpharma Us Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms THEOPHYLLINE theophylline SYRUP;ORAL 086545-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride CONCENTRATE;ORAL 087766-001 Apr 26, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) CREAM;VAGINAL 087864-001 Sep 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms CODAMINE hydrocodone bitartrate; phenylpropanolamine hydrochloride SYRUP;ORAL 075103-001 Sep 29, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms FLUOCET fluocinolone acetonide CREAM;TOPICAL 088360-001 Jan 16, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms BROMANYL bromodiphenhydramine hydrochloride; codeine phosphate SYRUP;ORAL 088343-001 Aug 15, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms ERYTHROMYCIN erythromycin SOLUTION;TOPICAL 062957-001 Jul 21, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride SOLUTION;ORAL 073187-001 Sep 15, 1992 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms HYDRAMINE diphenhydramine hydrochloride ELIXIR;ORAL 080763-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms THEOPHYLLINE theophylline SYRUP;ORAL 086001-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Alpharma Us Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-004 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms SERAX oxazepam CAPSULE;ORAL 015539-006 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Fuji
Accenture
Fish and Richardson
Boehringer Ingelheim
Mallinckrodt
UBS
Julphar
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot